EGFR and lung carcinoma: Cell experiments have shown that 68 has an effect on cardiac fibroblasts (CFs) and RAW264.7 macrophages and can be used as a potential dual inhibitor of EGFR and ATX in the treatment of pulmonary fibrosis caused by lung cancer [89].